Inspecting Candida Oral Infections among Diabetics

Autor/innen

  • Abeer Mohammed Ali Al-Garawyi
  • Sabreen Sami Abed
  • Mortadha Sami Abd
  • Majid Mohammed Mahmood Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq

DOI:

https://doi.org/10.5195/d3000.2024.717

Schlagworte:

Diabetes mellitus, Oral Candidiasis, Antifungal, Candida albicans, Nystatin

Abstract

Objective: Oral candidiasis infection is more prevalent in diabetic patients. There are numerous factors that can exacerbate the colonization of Candida species in the oral cavity, including salivary pH disorders and xerostomia. The study aimed to evaluate Candida spp. resistance to antifungal agents and compare their colonization levels in diabetics and nondiabetics oral cavities.

Methods: We conducted the investigation from February 2023 to April 2023. We conducted the following analyses after collecting 100 oral samples: gram stain, culture on Sabaroud dextrose agar, and direct microscopic inspection. The Vitek 2 System confirmed the yeasts through carbohydrate assimilation profiles.

Results: Out of 100 oral samples cultured, 69 yielded Candida species. Fifty-two samples were from diabetics and 17 were from nondiabetic patients. The frequencies of isolated Candida species, including C. albicans, were 28, C. tropicalis 17, C. krusei 16, C. glabrata 6, and C. dubliniensis 2. The results indicated that C. albicans exhibited higher resistance rates against clotrimazole, itraconazole, and voriconazole than the no albicans Candida species. Clotrimazole, itraconazole, and voriconazole, on the other hand, showed no effect on 11, 29, and 18 samples for all Candida species, respectively.

Conclusion: C. albicans was the most prevalent Candida species in people with diabetes; however, other Candida species were common. Fluconazole and nystatin often treat oral Candida infections.

Downloads

Veröffentlicht

2024-09-28

Ausgabe

Bd. 12 Nr. 2 (2024)

Rubrik

Adults & the Elderly

Lizenz

Copyright (c) 2024 Majid Mohammed Mahmood, Sabreem Sami Abed, Mortadha Sami Abd, Majid Mohammed Mahmood

Creative-Commons-Lizenz
Dieses Werk steht unter der Lizenz Creative Commons Namensnennung 4.0 International.

Authors who publish with this journal agree to the following terms:

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
    with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
  4. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
  5. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
  6. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
  7. The Author represents and warrants that:
    1. the Work is the Author’s original work;
    2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
    3. the Work is not pending review or under consideration by another publisher;
    4. the Work has not previously been published;
    5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
    6. the Work contains no libel, invasion of privacy, or other unlawful matter.
  8. The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Revised 7/16/2018. Revision Description: Removed outdated link.